In the last trading session, 1.01 million Generation Bio Co (NASDAQ:GBIO) shares changed hands as the company’s beta touched 2.71. With the company’s per share price at $0.53 changed hands at $0.05 or 10.42% during last session, the market valuation stood at $35.51M. GBIO’s last price was a discount, traded about -777.36% off its 52-week high of $4.65. The share price had its 52-week low at $0.47, which suggests the last value was 11.32% up since then. When we look at Generation Bio Co’s average trading volume, we note the 10-day average is 0.49 million shares, with the 3-month average coming to 535.82K.
Analysts gave the Generation Bio Co (GBIO) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.67. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended GBIO as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight.
Generation Bio Co (NASDAQ:GBIO) trade information
Instantly GBIO was in green as seen at the end of in last trading. With action 7.07%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -50.00%, with the 5-day performance at 7.07% in the green. However, in the 30-day time frame, Generation Bio Co (NASDAQ:GBIO) is -22.06% down. Looking at the short shares, we see there were 2.56 million shares sold at short interest cover period of 5.94 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -20.44%. The 2025 estimates are for Generation Bio Co earnings to increase by 43.69%, but the outlook for the next 5-year period is at 25.87% per year.
GBIO Dividends
Generation Bio Co is expected to release its next quarterly earnings report on 2025-Mar-12.
Generation Bio Co (NASDAQ:GBIO)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 14.35% of Generation Bio Co shares while 81.54% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 95.20%. There are 81.54% institutions holding the Generation Bio Co stock share, with PRICE T ROWE ASSOCIATES INC /MD/ the top institutional holder. As of 2024-06-30, the company held 14.3205% of the shares, roughly 9.51 million GBIO shares worth $26.83 million.
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC holds the second largest percentage of outstanding shares, with 12.4628% or 8.28 million shares worth $23.35 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were Price (T.Rowe) New Horizons Fund and Fidelity Growth Company Fund . With 5.34 shares estimated at $2.83 million under it, the former controlled 7.97% of total outstanding shares. On the other hand, Fidelity Growth Company Fund held about 2.65% of the shares, roughly 1.78 shares worth around $0.94 million.
